Voice of Regenerative Medicine : CIRM President Alan Trounson Abuses His CA Top State Official Position in CIRM to Cover Up His COI Alliance and Deny Appeal for Flawed Grant Reviews

Sunday, January 27, 2013

CIRM President Alan Trounson Abuses His CA Top State Official Position in CIRM to Cover Up His COI Alliance and Deny Appeal for Flawed Grant Reviews

California Institute for Regenerative Medicine (CIRM) President Alan Trounson abuses CIRM non-transparent pre-application to cover up his conflicts of interest (COI) alliance using procedural flaw in CIRM grant review, deny appeal for false or biased grant reviews containing anti-Prop 71 anti-hESC research COI comments, and abuses his California top state official position & power in CIRM to block bringing up human embryonic stem cell research (hESC) advances and medical innovations for consideration for public funds against law. Scientific grant review process is supposed to evaluate the scientific merit of applications, such as what is the significance; are there any scientific data to indicate the potential of success of this project; if success, what is the impact. CIRM reviewers’ comments, which are backed up by their top COI alliances in CIRM such as Alan Trounson, are full of biased or false statements, not even near to any standards of scientific grant review involving the consistent application of standards and procedures that produce fair, equitable, informed, and unbiased examinations of grant applications. Maybe, we should also remember that Alan Trounson have denied to bring up hESC grants for consideration against the law, so he could abuse his government official position and power to embezzle CA state funds for his luxury salary and COI alliances with no merit. See our previous posts.

Dear Dr. Trounson,

Could you please give a detailed explanation why you could not see any merit in our application (please see http://wwwsdrmiorg.blogspot.com & http://www.sdrmi.org/wordpress for editorial, press releases, & our publications for the merit you could not see or clouded by your COI). Maybe, we should also remember that you have denied to bring up hESC grants for consideration against the law, so you could abuse your government official position and power to embezzle CA state funds or public funds for hESC research for your luxury salary and to those who have COI alliances with no merit.

Thanks,

From: Alan Trounson [mailto:ATrounson@cirm.ca.gov]
Sent: Saturday, January 26, 2013 7:44 PM
To: parsons@SDRMI.org; Gil Sambrano
Cc: Jon Thomas; Ellen Feigal
Subject: Re: CIRM ET4 PreApp Review

Gil, I see no merit in this petition. Alan

No comments:

Post a Comment

Public Interest

The successful derivation of human embryonic stem cell (human ES cell) lines from the in vitro fertilization (IVF) leftover embryos is considered as one of the major breakthroughs of the life sciences. The pluripotent human ES cells, derived from the inner cell mass (ICM) or epiblast of human blastocyst or human embryos, have both the unconstrained capacity for long-term stable undifferentiated growth in culture and the intrinsic potential for differentiation into all somatic cell types in the human body, holding tremendous potential for human tissue and function restoration. Therefore, human ES cells have been regarded as an ideal source to provide an unlimited supply of large-scale well-characterized human specialized cell types for cell-based therapies to resolve some worldwide major health problems, such as neurodegenerative diseases, paralysis, diabetes, and heart diseases. A small portion of the millions of excess embryos currently stored in the IVF clinics worldwide, which are otherwise destined for destruction, could potentially be an unlimited source to deliver in the future a whole range of therapeutic treatments for tissue and function restoration in patients with life-threatening diseases and injuries. However, human ES cell research has generated intense public interest as well as controversy due to concerns of products of human ES cell cultures that can only be obtained by the use, involving their destruction, of human embryos. The recent years’ court battles on Federal funding for human ES cell research in the United State (US) as well as the patentability of US and international patents directed to human ES cell technologies have also highlighted the decade long ethical, moral, social, and legal controversy surrounding the public interest of human ES cells involving destruction, commercial or industrial uses of human embryos. As neurodegenerative and heart diseases incur exorbitant costs on the healthcare system worldwide, there is a strong focus on providing newer and more efficient solutions for these therapeutic needs. Millions of people are pinning their hopes on human ES cell research. California voters have passed Proposition 71 to designate $3B public fund to support pluripotent human ES cell research and therapy development for the benefit of public health. In spite of ethical debates surrounding the ownership and funding issues of human ES cells, in the case of many incurable or hitherto untreatable life-threatening or devastating diseases, supporting human ES cell research is crucial to driving the advance of medicine to provide optimal regeneration and reconstruction treatment options to improve the function, wellness, and overall quality of life. To answer the intense public interest surrounding human ES cell research and enormous public healthcare benefits thereof, Voice of Regenerative Medicine provides a ground of public debate or voice or blog for the controversies surrounding public interest of human ES cells centering on scientific, economic, ethical, moral, social, financial conflict of interest, and legal issues, to increase public awareness and understanding of the scientific advancement of human ES cell research, and of the importance, urgency, and tangible benefits of human ES cell-based regenerative medicine to improving the function, wellness, and overall quality of life for patients suffering from incurable or hitherto untreatable life-threatening or devastating diseases; to increase public support for human ES cell research; to improve policy making and funding situation for human ES cell research, and to identify and disclose publicly those scientific, economic, ethical, moral, social, financial conflict of interest, and legal issues that have impeded the progress of human ES cell research and stem cell therapy development, introduction of medical innovations and new business opportunities based on human ES cell research, and bringing new therapeutics into the market.

Disclaimer:

This “Voice of Regenerative Medicine” blog is to provide a public voice and an open forum to human embryonic stem cell research and regenerative medicine start-up. All content provided on this blog is for informational purposes only. This blog makes no representations as to accuracy, completeness, correctness, reliability, suitability, or validity of any information on this site or found by following any link on this site, and will not be liable for any errors or omissions or availability in this information, or any losses, injuries, or damages arising from the display or use of this information. The inclusion of any content, images, documents, files, and links on the blog does not necessarily imply a recommendation or endorse the views expressed within them. The content of any postings or comments on the blog do not necessary reflect or do not necessary represent the positions, strategies, views, or opinions of the owners, authors, bloggers, or San Diego Regenerative Medicine Institute or any organizations or any companies or any director, officer, or employee thereof. This blog is not associated with, affiliated with, a partner with, belonging to, or acting upon any organizations or individuals. The blog’s content is not generated to make money or paid for blogging content. It is natural for the content on the blog to be controversial or contentious. The content on the blog is the opinion only, not intended to malign any religion, ethnic group, club, organization, company, or individual, or anyone or anything. The owners, bloggers, San Diego Regenerative Medicine Institute, any individuals, any organizations, and any companies are not responsible, nor will be held liable, for the content or comments or the display or use of any information on the blog. Our intention is to do no harm, to not injure others, defame, or libel. All information is provided on an as-is basis. These terms and conditions are subject to change at anytime and without notice.